JOURNAL HOME CME HOME THIS MONTH PAST ISSUES ETOC COLLECTIONS
AUTHORS REVIEWERS EDITORIAL BOARD FEEDBACK RSS HELP
A&A International Anesthesia Research Society
 QUICK SEARCH:   [advanced]


     


Anesth Analg 1988; 67:205-210
© 1988 International Anesthesia Research Society
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Leone, B. J.
Right arrow Articles by Ryder, W. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Leone, B. J.
Right arrow Articles by Ryder, W. A.

Intravenous Diltiazem Worsens Regional Function in Compromised Myocardium

Bruce J. Leone, MD, Daniel M. Philbin, MD, Jean-Jacques Lehot, MD, Mark Wilkins, Pierre Foëx, MD Dphil, and W. Allen Ryder

Department of Anaesthetics, Oxford University, RadcliffeInfirmary, Oxford, United Kingdom.

Abstract

The effect of intravenous diltiazem on regional myocardial function was assessed in a canine model of critical constriction of the left anterior descending coronaryartery (LAD). Maintenance anesthesia with fentanyl (1.5 µg·kg–1. min–1), 60% inspired nitrous oxide, and 0.7% inspired halothane resulted in regional dysfunction, measured as postsystolic shortening (20.6 ± 10.7%), which was significantly worsened after 0.1 mg/kg (48.7 ± 12.5%, P < 0.05) and after 0.2 mg/kg (68.8 ± 71.7%, P < 0.05) intravenous diltiazem. Systolic shortening in the compromised LAD territory was substantially depressed after 0.1 mg/kg diltiazem (8.2 ± 0.6% to 5.3 ± 2.3%, P < 0.05) and was essentially abolished after 0.2 mg/kg diltiazem (8.2 ± 0.6% to 0.7 ±2.3%, P < 0.05). At the higher dose of diltiazem, cardiac output was substantially decreased (1.37 ± 0.23 L/min to 0.88 ± 0.30 L/min, P < 0.05) and LV dP/dtmax significantly depressed (1090 ± 90 mm Hg/sec to 744 ± 80 mm Hg/sec, P < 0.05). These resultsdemonstrate significant depression of regional systolic shortening and substantial worsening of regional dysfunction in myocardium with a compromised blood supply, in association with significant depression of left ventricular performance, with intravenous diltiazem administration during anesthesia.

Key Words: HEART, MYOCARDIAL FUNCTION—ischemia • IONS, CALCIUM ANTAGONISTS—diltiazem • PHARMACOLOGY—diltiazem







Lippincott, Williams & Wilkins Anesthesia & Analgesia® is published for the International Anesthesia Research Society® by Lippincott Williams & Wilkins with the assistance of Stanford University Libraries' HighWire Press®. Copyright 2006 by the International Anesthesia Research Society. Online ISSN: 1526-7598   Print ISSN: 0003-2999 HighWire Press
Copyright © 1988 by the International Anesthesia Research Society.